Forget This Biotech Stock’s Rally Signals Fresh Jump
NovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
Different volatility measures reveal different risk facets of stock indices. This primer clarifies what each metric means for decisions.
23,218 articlesNovaGen Therapeutics rockets after a major AI-driven deal, highlighting a rare biotech upside amid a cooling AI market.
A fresh cash bid for Two Harbors Investment Corp. sparks a renewed bidding war, putting pressure on UWM to top terms ...
This in-depth look breaks down Unity's Q1 2026 earnings call, outlining revenue drivers, profitability, and what the ...
Cisco posts record quarterly revenue as AI infrastructure orders rise, fueling renewed bets on CSCO. The article exam...
Credo Technology faces a pivotal Q4 print as analysts and traders dissect margins, inventory builds, and AI demand si...
Four billionaire investors from divergent strategies quietly increased bets on a leading chipmaker, signaling a broad...
A strong quarter from TSMC is more than a one-off beat. This analysis explains why tsmc's revenue grew last and how c...
A once-hot stock that rode the COVID surge now sits far from its peak. This piece breaks down how wall street erases ...
Baidu shares slumped after a hefty impairment charge underscored the heavy costs of its AI push, even as AI Cloud rev...
XPeng reported a rare quarterly profit in Q4 2025 but warned of a softer start to 2026, sending shares lower as inves...
Year after year, the smartest way to build lasting wealth is a disciplined, buy-and-hold approach to dividend stocks....
As the first-quarter report for Innovate lands, investors eye more than just the top line. This guide breaks down wha...